Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2004-12-10
2009-06-30
Kemmerer, Elizabeth C. (Department: 1649)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S006120, C435S007930, C435S007940, C435S007950, C435S007100
Reexamination Certificate
active
07553631
ABSTRACT:
Methods for screening molecules that modulate the activity of Retinol Binding Protein 4 (RBP4) and their use in treatment of insulin resistance are described. Also described are methods of diagnosing insulin resistance and related conditions by detecting modulation of RBP4 activity.
REFERENCES:
patent: 5399757 (1995-03-01), Maryanoff
patent: 6117845 (2000-09-01), Clagett-Dame et al.
patent: 6544790 (2003-04-01), Sabatini
patent: 2002/0006664 (2002-01-01), Sabatini
patent: 2003/0013093 (2003-01-01), Attie et al.
patent: 2003/0032203 (2003-02-01), Sabatini et al.
patent: WO 02/22886 (2002-03-01), None
patent: WO 2004/011618 (2004-02-01), None
patent: WO 2005/059564 (2005-06-01), None
patent: WO 2006/052860 (2006-05-01), None
patent: WO 2006/063128 (2006-06-01), None
Basualdo et al. Journal of the American College of Nutrition, 16(1): 39-45, Feb. 1997.
UniProtKB/Swiss-Prot entry P02753, Jul. 1986.
Shi et al. Journal of Chromatography B: Biomedical Applications, 665: 89-96, Jan. 1995.
de Pee et al., The Journal of Nutrition, 132: 2895S-2901S, Sep. 2002.
Merritt et al., The American Journal of Clinical Nutrition, 34: 2752-2753, Dec. 1981.
DesPrés, J.-P., et al., “Hyperinsulinemia as an Independent Risk Factor for Ischemic Heart Disease,”N. Engl. J. Med., 334(15):952-957 (1996).
Shepherd, P. R., et al., “Adipose Cell Hyperplasia and Enhanced Glucose Disposal in Transgenic Mice Overexpressing GLUT4 Selectively in Adipose Tissue,”J. Biol. Chem. 268(30):2243-2246 (1993).
Abel, E. D., et al., “Adipose-selective Targeting of theGLUT4Gene Impairs Insulin Action in Muscle and Liver,”Nature 409:729-733 (2001).
Tozzo, E., et al., “Amelioratin of Insulin Resistance in Streptozotocin Diabetic Mice by Transgenic Overexpression of GLUT4 Driven by an Adipose-Specific Promoter,”Endocrinology 138(4):1604-1611 (1997).
Minokoshi, Y., et al., “Tissue-specific Ablation of the GLUT4 Glucose Transporter or the Insulin Receptor Challenges Assumptions about Insulin Action and Glucose Homeostasis,”J. Biol. Chem. 278(36):33609-33612 (2003).
Blaner, W. S., “Retinol-Binding Protein: The Serum Transport Protein for Vitamin A,”Endocr. Rev. 10(3):308-316 (1989).
Lee, C.-H., et al., “Minireview: Lipid Metabolism, Metabolic Diseases, and Peroxisome Proliferator-Activated Receptors,”Endocrinology 144(6):2201-2207 (2003).
Malpeli, G., et al., “Retinoid Binding to Retinol-binding Protein and the Interference with the Interaction with Transthyretin,”Biochimica et Biophysica Acta 1294:48-54 (1996).
Basualdo, C. G., et al., “Vitamin A (Retinol) Status of First Nation Adults with Non-Insulin-Dependent Diabetes Mellitus,”J. Am. Coll. Nutr. 16(1):39-45 (1997).
Chambon, P., “A Decade of Molecular Biology of Retinoic Acid Receptors,”FASEB J. 10:940-954 (1996).
Sivaprasadarao, A., et al. “The Interaction of Retinol-Binding Protein with its Plasma-Membrane Receptor,”Biochem. J. 255(2):561-569 (1988).
Matarese, V., and Lodish, H.F.,“Specific Uptake of Retinol-binding Protein by Variant F9 Cell Lines,”J. Biol. Chem., 268(25):18859-18865 (1993).
Christensen, E.I., et al., “Evidence for an Essential Role of Megalin in Transepithelial Transport of Retinol,”J. Am. Soc. Nephrol. 10:685-695 (1999).
Berni, R., et al., “Retinoids: In Vitro Interaction with Retinol-binding Protein and Influence on Plasma Retinol,”FASEB J. 7:1179-1184 (1993).
Sheikh, M.S., et al., “N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated Biological Actions Involve Retinoid Receptor-Independent Pathways in Human Breast Carcinoma,”Carcinogenesis 16(10):2477-2486 (1995).
Um, S.-J., et al., “Antiproliferative Mechanism of Retinoid Derivatives in Ovarian Cancer Cells,”Cancer Lett. 174:127-134 (2001).
Shen, Q., et al., “Effects of Rexinoids on Glucose Transport and Insulin-mediated Signaling in Skeletal Muscles of Diabetic (db/db) Mice,”J. Biol. Chem. 279(19):19721-19731 (2004).
Kim, Y.-B., et al., “Glucosamine Infusion in Rats Rapidly Impairs Insulin Stimulation of Phosphoinositide 3-Kinase but does not Alter Activation of Akt/Protein Kinase B in Skeletal Muscle,”Diabetes 48:310-320 (1999).
Wang, T.T.Y., et al., “Production of Human Plasma Retinol-binding Protein inEscherichia coli,” Gene 133(2):291-294 (1993).
Xie, Y., et al., “Recombinant Human Retinol-Binding Protein Refolding, Native Disulfide Formation, and Characterization,”Protein Express. Purif. 14:31-37 (1998).
Basu, T.K., et al., “Serum Vitamin A and Retinol-Binding Protein in Patients with Insulin-dependent Diabetes Mellitus,”Am. J. Clin. Nutr. 50:329-331 (1989).
Kemp, S.F., and Frindik, J.P., “Effect of Metabolic Control on Serum Protein Concentrations in Diabetes”Acta Pœdiatr. Scand. 80(10):938-943 (1991).
Gnudi, L., et al., “Adipose-specific Overexpression of GLUT-4 in Transgenic Mice Alters Lipoprotein Lipase Activity,”Am. J. Physiol. 270(4):R785-R792 (1996).
Lorenzo, C., et al., “The Metabolic Syndrome as Predictor of Type 2 Diabetes,”Diabetes Care 26(11):3153-3159 (2003).
Osei, K., et al., “Is Glycosylated Hemoglobin Alc a Surrogate for Metabolic Syndrome in Nondiabetic, First-Degree Relatives of African-American Patients with Type 2 Diabetes?,”J. Clin. Endocrinol. Metab. 88(10):4596-4601 (2003).
Shi, H., et al., “Determination of Vitamin A in Dried Human Blood Spots by High-performance Capillary Electrophoresis with Laser-Excited Fluorescence Detection,”J. Chromatogr. B 665:89-96 (1995).
Basu, T.K., et al., “Vitamin A Homeostasis and Diabetes Mellitus,”Nutrition 13(9):804-806 (1997).
Meigs, J.B., “The Metabolic Syndrome,”BMJ 327:61-62 (2003).
Carvalho, E., et al., “Overexpression of Glut4 in Fat “Rescues” Glucose Intolerance in Muscle-Specific Glut4 Knockout Mice,”Journal of the American Diabetes Association 51Supplement (2): (FromDiabetes Abstract Book, 2002, A326, Abstract No. 1333-P).
Craft, N.E., “Innovative Approaches to Vitamin A Assessment,”American Society for Nutritional Sciences131:1626S-1630S (2001).
Dykxhoorn, D.M., et al., “Killing the Messenger: Short RNAs that Silence Gene Expression,”Nature Rev., 4:457-467 (2003).
Tanumihardjo, S.A., et al., “Dried Blood Spot Retinol and Retinol-binding Protein Concentrations Using Enzyme Immunoassay as Surrogates of Serum Retinol Concentrations,” MOST Technical Report. Arlington, Virginia, pp. 1-17 (2002).
Abahusain, M.A., et al., “Retinol, α-tocopherol and Carotenoids in Diabetes,”Eur. J. Clin. Nutr. 53:630-635 (1999).
Jessen, K.A., and Satre, M.A., “Mouse Retinol Binding Protein Gene: Cloning, Expression and Regulation by Retinoic Acid,”Mol. Cell. Biochem., 211(1-2): 85-94 (2000).
Fukenstein, B., “Developmental Expression, Tissue Distribution and Hormonal Regulation of Fish (Sparus aurata) Serum Retinol-Binding Protein,”Comp. Biochem. Physiol. B, 129(2-3), 613-622 (2001).
Berni, R., et al., “In Vitro Interaction Of Fenretinide With Plasma Retinol-Binding Protein and Its Functional Consequences,”FEBS Lett., 308(1): 43-45 (1992).
Schaffer, E.M., et al., “N-(4-Hydroxyphenyl)retinamide (Fenretinide) Induces Retinol-Binding Protein Secretion from Liver and Accumulation in the Kidneys in Rats,”J. Nutr., 123(9): 1497-1503 (1993).
Saltiel, A.R., and Olefsky, J.M., “Thiazolidinediones In The Treatment of Insulin Resistance and Type II Diabetes,”Diabetes, 45(12): 1661-1669 (1996).
Graham Tim
Kahn Barbara B.
Peroni Odile
Yang Qin
Ballard Kimberly A.
Beth Israel Deaconess Medical Center Inc.
Hamilton Brook Smith & Reynolds P.C.
Kemmerer Elizabeth C.
LandOfFree
RBP4 in insulin sensitivity/resistance, diabetes, and obesity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with RBP4 in insulin sensitivity/resistance, diabetes, and obesity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and RBP4 in insulin sensitivity/resistance, diabetes, and obesity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4052639